Search

Charles Searby Phones & Addresses

  • 24 Penfro Dr, Iowa City, IA 52246 (319) 338-6813
  • 608 Westgate St, Iowa City, IA 52246 (319) 338-6813
  • 547 Emerald St, Iowa City, IA 52246 (319) 338-6813
  • 608 Westgate St APT 17, Iowa City, IA 52246

Work

Position: Administrative Support Occupations, Including Clerical Occupations

Education

Degree: High school graduate or higher

Resumes

Resumes

Charles Searby Photo 1

Research Specialist

View page
Location:
Iowa City, IA
Industry:
Philanthropy
Work:
University of Iowa
Research Specialist

Howard Hughes Medical Institute Jul 1997 - Aug 2015
Research Technician

University of Iowa Jan 1981 - Jul 1997
Research Assistant Iii
Education:
The University of Iowa 1976 - 1980
Bachelors, Bachelor of Science, Biochemistry
Skills:
Molecular Cloning
Western Blotting
Molecular Biology
Protein Purification
Protein Expression
Biochemistry
Fluorescence Microscopy
Cell Culture
Cell Biology
Pcr
Confocal Microscopy
Transfection
Protein Chemistry
Immunohistochemistry
Genetics
Microscopy
Qpcr
Tissue Culture
Immunofluorescence
Cell
Polymerase Chain Reaction
Animal Models
Charles Searby Photo 2

Charles Searby

View page

Publications

Us Patents

Identification Of A Gene Causing The Most Common Form Of Bardet-Biedl Syndrome And Uses Thereof

View page
US Patent:
20030232375, Dec 18, 2003
Filed:
May 28, 2003
Appl. No.:
10/447322
Inventors:
Val Sheffield - Iowa City IA, US
Kirk Mykytyn - Iowa City IA, US
Darryl Nishimura - Coralville IA, US
Edwin Stone - Iowa City IA, US
Charles Searby - Iowa City IA, US
Assignee:
The University of Iowa Research Foundation
International Classification:
C12Q001/68
C07H021/04
C12P021/02
C12N005/06
C07K014/705
C12N015/86
US Classification:
435/006000, 435/069100, 435/456000, 435/320100, 435/325000, 530/350000, 536/023500
Abstract:
The present invention relates to the identification of a gene, mutated at the most common locus now designated BBS1, that is involved in the genetic disease Bardet Biedl Syndrome (BBS), which is characterized by such diverse symptoms as obesity, diabetes, hypogonadism, mental retardation, renal cancer and other renal abnormalities, retinopathy and polydactyly or limb deformities. The human BBS1 protein disclosed herein is composed of 17 exons and spans approximately 23 kb. Methods of use for the gene, for example in diagnosis and therapy of BBS and in drug screening, also are described.

Identification Of A Gene Causing The Most Common Form Of Bardet-Biedl Syndrome And Uses Thereof

View page
US Patent:
20060110761, May 25, 2006
Filed:
Nov 8, 2005
Appl. No.:
11/269167
Inventors:
Val Sheffield - Iowa City IA, US
Kirk Mykytyn - Iowa City IA, US
Darryl Nishimura - Coralville IA, US
Edwin Stone - Iowa City IA, US
Charles Searby - Iowa City IA, US
International Classification:
C12Q 1/68
C07H 21/04
C12P 21/06
C07K 14/47
US Classification:
435006000, 435069100, 435320100, 435456000, 435325000, 530350000, 536023500
Abstract:
The present invention relates to the identification of a gene, mutated at the most common locus now designated BBS1, that is involved in the genetic disease Bardet Biedl Syndrome (BBS), which is characterized by such diverse symptoms as obesity, diabetes, hypogonadism, mental retardation, renal cancer and other renal abnormalities, retinopathy and polydactyly or limb deformities. The human BBS1 protein disclosed herein is composed of 17 exons and spans approximately 23 kb. Methods of use for the gene, for example in diagnosis and therapy of BBS and in drug screening, also are described.

Therapeutic Systems Using Magnetic And Electric Fields

View page
US Patent:
20210339035, Nov 4, 2021
Filed:
Jul 7, 2021
Appl. No.:
17/369784
Inventors:
- Iowa City IA, US
Sunny C. Huang - Iowa City IA, US
Michael J. Miller - Iowa City IA, US
Charles C. Searby - Iowa City IA, US
Val C. Sheffield - Iowa City IA, US
International Classification:
A61N 2/00
A61B 5/145
A61N 2/06
A61N 1/10
A61N 1/40
A61N 1/36
A61N 1/04
Abstract:
An example of subject may deliver a therapy by delivering energy to tissue. The system may comprise a magnetic field system and an electric field system. The magnetic field system may be configured to provide a magnetic field in a first direction to the tissue. The magnetic field system may include at least one magnetic field source to produce the magnetic field. The magnetic field produced by the at least one magnetic field source may include a magnetic field produced by at least one of a permanent magnet, a temporary magnet or electric current flow through a conductor. The electric field system may be configured to provide an electric field in a second direction to the tissue. The electric field system may include at least one electric field source to provide the electric field and the second direction is non-parallel to the first direction.

Therapeutic Systems Using Magnetic Fields

View page
US Patent:
20210052910, Feb 25, 2021
Filed:
Aug 19, 2020
Appl. No.:
16/947824
Inventors:
- Iowa City IA, US
Sunny C. Huang - Iowa City IA, US
Michael J. Miller - Iowa City IA, US
Charles C. Searby - Iowa City IA, US
Val C. Sheffield - Iowa City IA, US
International Classification:
A61N 2/00
A61N 2/06
A61N 2/02
Abstract:
A system may comprise one, two or more magnetic field systems. The magnetic field system may be configured to provide a magnetic field in a first direction to the tissue. The magnetic field system may include at least one magnetic field source to produce the magnetic field. The magnetic field produced by the at least one magnetic field source may include a magnetic field produced by at least one of a permanent magnet, a temporary magnet or electric current flow through a conductor. The same or a second magnetic field system may be configured to provide a second magnetic field in a second direction to the tissue. The magnetic field system may include two or more sources to provide the magnetic field in a second, third or fourth direction that is non-parallel to the first direction.

Therapeutic Systems Using Magnetic And Electric Fields

View page
US Patent:
20190255344, Aug 22, 2019
Filed:
Feb 20, 2019
Appl. No.:
16/280551
Inventors:
- Iowa City IA, US
Sunny C. Huang - Iowa City IA, US
Michael J. Miller - Iowa City IA, US
Charles C. Searby - Iowa City IA, US
Val C. Sheffield - Iowa City IA, US
International Classification:
A61N 2/00
A61B 5/145
A61N 2/06
A61N 1/10
A61N 1/04
A61N 1/36
Abstract:
An example of subject may deliver a therapy by delivering energy to tissue. The system may comprise a magnetic field system and an electric field system. The magnetic field system may be configured to provide a magnetic field in a first direction to the tissue. The magnetic field system may include at least one magnetic field source to produce the magnetic field. The magnetic field produced by the at least one magnetic field source may include a magnetic field produced by at least one of a permanent magnet, a temporary magnet or electric current flow through a conductor. The electric field system may be configured to provide an electric field in a second direction to the tissue. The electric field system may include at least one electric field source to provide the electric field and the second direction is non-parallel to the first direction.
Charles C Searby from Iowa City, IA, age ~67 Get Report